首页|西维来司他钠对急性Stanford A型主动脉夹层手术患者术后谵妄的预防作用及其机制

西维来司他钠对急性Stanford A型主动脉夹层手术患者术后谵妄的预防作用及其机制

扫码查看
目的 探讨西维来司他钠对急性Stanford A型主动脉夹层(ATAAD)患者术后谵妄(POD)的预防作用及其机制。方法 纳入急诊行ATAAD手术患者80例,跟据随机数字表法分为西维来司他钠组及对照组各40例。西维来司他钠组于手术麻醉诱导前10 min静脉泵注西维来司他钠直至手术结束,对照组以相同的速率静脉泵注相同体积的生理盐水直至手术结束。术后3 d内采用3 min谵妄诊断量表(3D-CAM)对患者POD发生情况进行评估;于术后24 h时采集患者外周静脉血,采用改良的Ficoll密度梯度离心法提取外周血单个核细胞(PBMCs),比色法检测PBMCs内铁离子(Fe2+)浓度、丙二醛(MDA)含量及超氧化物歧化酶(SOD)活性,Western blotting法检测PBMCs内长链脂酰辅酶A合成酶(ACSL4)及谷胱甘肽过氧化物酶4(GPX4)蛋白。记录围手术期情况及不良反应发生情况。结果 西维来司他钠组POD发生率低于对照组(P<0。05),两组POD严重程度评分及POD持续时间比较差异均无统计学意义。西维来司他钠组PBMCs内Fe2+浓度及MDA含量低于对照组,SOD活性高于对照组(P均<0。05)。西维来司他钠组PBMCs内ACSL4蛋白表达低于对照组,GPX4蛋白表达高于对照组(P均<0。05)。西维来司他钠组ICU入住时间及术后住院时间少于对照组(P均<0。05);两组不良反应发生率差异均无统计学意义。结论 西维来司他钠可预防急性ATAAD手术患者POD的发生,其机制可能与抑制铁死亡从而减轻神经损伤有关。
Preventive effect and mechanism of sivelestat sodium on postoperative delirium in patients undergoing emergency surgery for acute Stanford type A aortic dissection
Objective To investigate the preventive effect of sivelestat sodium on postoperative delirium(POD)in patients with acute Stanford type A aortic dissection(ATAAD)and its mechanisms.Methods Eighty patients undergo-ing emergency surgery for ATAAD were included.They were randomly divided into two groups:the sivelestat sodium group(n=40)and the control group(n=40).In the sivelestat sodium group,sivelestat sodium was intravenously infused at a rate of 10 minutes before the induction of anesthesia until the end of the surgery.In the control group,an equal volume of normal saline was intravenously infused at the same rate until the end of the surgery.The occurrence of postoperative deliri-um(POD)was assessed using the 3-minute Diagnostic Assessment for Confusion Assessment Method(3D-CAM).Periph-eral venous blood samples were collected at 24 h after surgery to extract peripheral blood mononuclear cells(PBMCs)us-ing a modified Ficoll density gradient centrifugation method.The concentration of iron ions(Fe2+),malondialdehyde(MDA)content,and superoxide dismutase(SOD)activity in PBMCs were measured using colorimetric assay.The protein levels of long-chain acyl-CoA synthetase 4(ACSL4)and glutathione peroxidase 4(GPX4)in PBMCs were assessed using Western blotting.Perioperative adverse events were recorded.Results The incidence of POD in the cilostazol sodium group was lower than that in the control group(P<0.05),but there were no significant differences in the severity score or duration of POD between the two groups.The cilostazol sodium group had lower Fe2+ concentration and MDA content,and higher SOD activity in PBMCs than the control group(all P<0.05).The expression of ACSL4 protein in PBMCs was low-er,while the expression of GPX4 protein was higher in the cilostazol sodium group than in the control group(all P<0.05).Compared with the control group,the cilostazol sodium group had shorter ICU stay and postoperative hospitalization(both P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups.Conclusion Sivelestat sodium may prevent the occurrence of POD in patients with ATAAD,and its mechanism may be related to the in-hibition of ferroptosis,thereby reducing neurological damage.

sivelestat sodiumaortic dissectionpostoperative complicationspostoperative deliriumferroptosis

马红霞、卢星、袁野、吴光玲

展开 >

河南省胸科医院 郑州大学附属胸科医院麻醉科,郑州 450000

西维来司他钠 主动脉夹层 术后并发症 术后谵妄 铁死亡

河南省医学科技攻关计划—联合共建项目

LHGJ20210243

2024

山东医药
山东卫生报刊社

山东医药

CSTPCD
影响因子:1.225
ISSN:1002-266X
年,卷(期):2024.64(5)
  • 15